James Kuo

James Kuo is a declared insider of Tryp Therapeutics Inc., with filings sourced from SEDI. Over a trading history stretching from 24 September 2019 to 22 May 2022, the count stands at 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 26 May 2022: an option exercise of €25k, in Tryp Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.